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Abstract
Background: Managing the care of older adults with heart failure (HF) largely centers on medication management. Because
of frequent medication or dosing changes, an app that supports these older adults in keeping an up-to-date list of medications
could be advantageous. During the COVID-19 pandemic, HF outpatient consultations are taking place virtually or by telephone.
An app with the capability to share a patient’s medication list with health care professionals before consultation could support
clinical efficiency, for example, by reducing consultation time. However, the influence of apps on maintaining an up-to-date
medication history for older adults with HF in Ireland remains largely unexplored.
Objective: The aims of this review are twofold: to review apps with a medication list functionality and to assess the quality of
the apps included in the review using the Mobile App Rating Scale (MARS) and the IMS Institute for Healthcare Informatics
functionality scale.
Methods: A systematic search of apps was conducted in June 2019 using the Google Play Store and iTunes App Store. The
MARS was used independently by 4 researchers to assess the quality of the apps using an Android phone and an iPad. Apps were
also evaluated using the IMS Institute for Healthcare Informatics functionality score.
Results: Google Play and iTunes App store searches identified 483 potential apps (292 from Google Play and 191 from iTunes
App stores). A total of 6 apps (3 across both stores) met the inclusion criteria. Of the 6 apps, 4 achieved an acceptable MARS
score (3/5). The Medisafe app had the highest overall MARS score (4/5), and the Medication List & Medical Records app had
the lowest overall score (2.5/5). On average, the apps had 8 functions based on the IMS functionality criteria (range 5-11). A total
of 2 apps achieved the maximum score for number of features (11 features) according to the IMS Institute for Healthcare Informatics
functionality score, and 2 scored the lowest (5 features). Peer-reviewed publications were identified for 3 of the apps.
Conclusions: The quality of current apps with medication list functionality varies according to their technical aspects. Most of
the apps reviewed have an acceptable MARS objective quality (ie, the overall quality of an app). However, subjective quality
(ie, satisfaction with the apps) was poor. Only 3 apps are based on scientific evidence and have been tested previously. A total
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of 2 apps featured all the IMS Institute for Healthcare Informatics functionalities, and half did not provide clear instructions on
how to enter medication data, did not display vital parameter data in an easy-to-understand format, and did not guide users on
how or when to take their medication.
(JMIR Mhealth Uhealth 2021;9(11):e30674) doi: 10.2196/30674
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Introduction
Background
Managing the care of older adults with heart failure (HF) largely
centers on symptom and medication management [1].
Medication management in patients with HF is challenging due
to frequent medication or dosing changes [2,3] and
polypharmacy, as some patients with HF typically take on
average 10-25 tablets daily [4]. Polypharmacy is associated
with poor adherence to pharmacological therapies, drug
interactions, inappropriate drug prescriptions, and other adverse
effects [5]. A recent report by the World Health Organization
[6] argues that technology can improve patient experiences and
medication adherence and enable patients to become active
participants in medication reviews. Mobile apps offer the
potential to augment care for patients with HF. Apps can
potentially support older adults to find information on the
medications (ie, drug interactions), track their medication,
communicate with health care providers, keep a daily record of
their blood pressure and weight measurements, and facilitate
an accurate medication history. However, there is a dearth of
literature on apps specifically to support medication history.
An accurate medication list prevents adverse drug events [7],
increases patients’care outcomes, decreases hospitalization and
mortality rates [8,9], and supports medication adherence for
patients self-managing at home.
Given the complexity of HF self-care, assisting older adults in
managing their own care at home is critical to the success of
HF management. Emerging evidence suggests that mobile health
(mHealth), particularly mobile technologies, can serve as a form
of support for patients with HF and may enhance
patient-provider collaboration for self-management [1,10]. By
their nature, mobile devices, such as phones, are carried by
people and, therefore, are always with them, offering
opportunities beyond simple remote monitoring to assist with
the management of care. In the current context of the COVID-19
pandemic, when the community (and especially older adults)
is requested to maintain social distancing, the public health
landscape is changing and mHealth has never been so important
for treatment [10,11].
For older adults, social isolation and loneliness increase the risk
of anxiety, depression symptoms, heart disease, reduction of
activities of daily living, morbidity, and mortality [12,13].
Government recommendations to self-isolate during this
pandemic have undoubtedly had a detrimental effect on older
adults, including those that previously had wide social
connections with the community and relatives [14]. Older adults
who were previously attending outpatient appointments have
seen their access restricted. In Ireland, the Health Service
Executive website notes that all outpatient appointments are
postponed until further notice [15]. Health care professionals
(HCPs) working in outpatient clinics are seeing a reduced
number of patients, with most consultations now taking place
over the phone, bar medical emergencies. In Ireland, McGlynn
[16] drew attention to the sharp decline in cardiac outpatient
appointments during March to April 2020 (300,000
appointments) compared with the same period in 2019.
Therefore, the need for new models of care in this changed
environment to support older adults at home to alleviate their
mental and physical burden, as well as provide medical care, is
especially timely [10,11].
Across many countries, emerging evidence confirms the
important role that mHealth can play in community care,
especially during COVID-19. In the United States, there have
been 10-fold web-based consultations in a few weeks [17], “...as
big a transformation as any ever before in the history of US
health care.” Similarly, Canada, South Africa, India, and the
United Kingdom are conducting health care web-based
consultations at an exponential rate [17]. In Ireland, the platform
Attend Anywhere, endorsed by the Health Service Executive,
is now widely available for HCPs to conduct web-based
consultations [18]. However, the use of this platform is not even
across Irish clinical settings (some HCPs are actively using it
and others are not). Many outpatient services are consulting
patients over the phone during the COVID-19 pandemic [19,20],
except for patients with exacerbated symptoms.
The process of medication review over the phone is difficult
and time-consuming [21]. HCPs have to listen attentively to the
information the patient is conveying while lacking visual cues
(ie, printed medication list or medication blisters provided by
pharmacists). Instead, each patient has to spell each medication
list over the phone, raising confusion over similarities of the
medication name or dose, thus increasing the length of the
consultation. An app sharing an up-to-date medication list with
HCPs preconsultation could reduce medication and dosing
errors, making the consultation process more efficient. A
usability study of an app developed for HF self-management
was conducted in Australia [22]. A total of 8 participants tested
the app over a 14-day period and 6 of them assessed the app
using the Mobile App Rating Scale (MARS; widely used to
assess the quality of mobile apps). The app was found to be of
acceptable quality and beneficial for HF self-management.
Interestingly, the medication list feature on the app was
considered by the patients to be beneficial; however, none of
the patients used it during the 14 days. The authors suggested
that participants found it difficult to incorporate the app into
their self-care routine [22].
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Emerging evidence suggests that apps can support patients by
checking drug interactions, tracking medication intake, and
facilitating an up-to-date list of medications. However, although
some app interventions have explored HF self-management
[23,24], app interventions focusing on older adults with HF
maintaining an accurate medication list have been limited and
largely unexplored. This paper aims to explore the benefits of
apps with a medication list functionality, explore their role in
the COVID-19 pandemic context, and assess their quality using
the MARS and the IMS Institute for Healthcare Informatics
functionality score.
Objectives
The objectives of this review are two-fold: to review apps with
a medication list functionality and to evaluate the quality of the
apps included in the review with a validated scale. To assess
the quality and functionality of the apps, 2 tools were used: the
MARS tool and the IMS Institute for Healthcare Informatics
functionality score. For the purpose of this paper, an app with
a medication list functionality is an app that generates a
comprehensive medication history, allowing the patient to email
or share the list in real time with HCPs.
Methods
Overview
A systematic search of apps accessible in Ireland was conducted
in June 2019 using the Google Play and iTunes App stores. The
purpose of this search was to identify apps with a medication
list functionality. The search term medication list was used to
identify apps with a medication list functionality. The term
medication app was excluded from the search as it identified
apps with a different primary purpose (eg, medication alarm,
medication tracker, medication reminder, apps providing
educational information only, medical decision support systems
for clinicians, medication adverse effect, pharmacy locator, and
prescription refills). After the initial identification of apps
containing a medical list function, the apps were tabulated. If
the same app was available on different platforms (iOS or
Android), both versions were retained for analysis as apps
behave differently depending on the platform, as seen in
previous work by Nicholas et al [25]. Inclusion and exclusion
criteria (discussed next) were applied to each app to determine
whether they should be retained for further analysis.
Apps that met the inclusion criteria were downloaded and
evaluated by a team of 4 researchers. The MARS was used to
assess the quality of the apps using an Android phone and an
iPad. Apps were also evaluated using the IMS Institute for
Healthcare Informatics functionality scores.
A Google Scholar search of the apps was conducted to identify
apps included in this review that have been evaluated and
published in peer-reviewed journals.
Inclusion and Exclusion Criteria
Apps were included if they had a medication list function; if
they were updated in the last 2 years; were free of charge,
reflecting popular trends in app downloads [26]; were available
in English; and had a strict privacy policy written on their
website or app store. Although a strict privacy policy is not an
ultimate standard, given the sensitive nature of health
information, the presence of a transparent privacy policy on
medication apps was deemed highly important [27].
Apps were excluded from evaluation if they were a game app,
were not available in Ireland, focused solely on a particular
medical condition (eg, asthma), were a mobile clinical decision
support system, were designed primarily for self-care
management of a condition (eg, chronic obstructive pulmonary
disease or diabetes), were not available for patients to use at
home, and had a barcode scanner that did not recognize
medication used in Ireland.
Data Extraction
The following information for each app with a medication list
function was downloaded: developer, number of downloads of
the app, last update, and description of the app in the app store.
The apps were downloaded from the app store, and scientific
support was evaluated by investigating their content. Scientific
support provides information on the app’s evidence of validity,
as apps that are not supported by evidence are associated with
decrements in quality and safety [28]. For example, issues
relating to patient confidentiality, inadequate content present
in the app, and malfunctioning clinical decision-making apps
could result in negative health outcomes for patients [29]. Apps
that fulfilled the inclusion criteria were assessed using the
MARS and IMS Institute for Healthcare Informatics
functionality scoring criteria [30].
Rating Tools
MARS Description
All apps were subjected to in-depth analysis and evaluation
using the MARS. To the best of our knowledge, there are no
published studies using the MARS to assess the quality of apps
with a medication list functionality. The MARS was developed
by a team of researchers at the University of Queensland,
Australia, to provide a systematic means of assessing,
classifying, and rating the quality of mHealth apps [31].
Within this framework, apps are rated according to 4 objective
measures (engagement, functionality, aesthetics, and information
quality) and one subjective measure (Table 1). More specifically,
engagement involves determining whether the app is fun,
interesting, customizable, interactive, and well-targeted to its
audience. Functionality assesses whether the app is easy to learn,
navigate, and flow logically. The esthetics category evaluates
the graphic design, overall visual appeal, color scheme, and
stylistic consistency of the app. Information quality involves
evaluating whether the app contains high-quality information
from a credible source. Subjective quality reflects user
satisfaction, app endorsement, and continuity of use (ibid). A
complete description of the MARS items and subscales can be
found in Multimedia Appendix 1 [31].
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The apps were independently reviewed by 4 reviewers using a
five-point scale (1=inadequate, 2=poor, 3=acceptable, 4=good,
and 5=excellent), as shown in Multimedia Appendix 2. Scores
for each category were obtained by calculating the mean of the
ratings for each subscale according to the 5 measures described
above. The total score for each app was determined using the
average of the 4 objective measures. The overall mean app
quality total score and the total score for the subjective measure
(subjective quality, worth recommending, repeat use of the app,
and overall satisfaction) were also calculated.
The reviewers carefully read the MARS instructions,
independently reviewed the apps, and provided a rationale for
their ratings. Subsequently, they compared the results and
reached a consensus on each of the ratings for each of the MARS
subscales [31]. Before rating the included apps, each reviewer
rated 2 randomly selected apps for training purposes (from those
apps that were excluded from the review). The results were
discussed to ensure that all reviewers had an understanding of
the MARS items and the rating process.
IMS Institute for Healthcare Informatics Functionality
Score Description
To complement the MARS quality assessment, another tool
was used to independently evaluate app functionalities [30].
This evaluation focused on the scope of functions and the
potential role that each functionality plays in supporting
self-management for patients with HF.
Unlike MARS, this tool only assesses objective quality and has
been used previously to evaluate app capabilities [32,33]. The
functionality score consists of 7 functionality criteria and 4
functional subcategories. The complete structure of the IMS
Institute for Healthcare Informatics functionality scoring criteria
can be found in Multimedia Appendix 3 [30]. If a function was
present, it was coded as 1; otherwise, it was coded as 0.




Google Play and iTunes App stores searches identified 483
potential apps (292 Google Play stores and 191 iTunes App
stores), the app selection process for both app stores can be seen
in Multimedia Appendices 4 and 5. A total of 6 apps (3 across
both stores) met the inclusion criteria. Out of the 6 apps
reviewed, 4 achieved an acceptable quality score (MARS score
3/5), one achieved a good quality score (4/5), and one had a
poor quality score (2.5/5). The median overall MARS score
was 3.5/5, ranging from 2.5/5 to 4/5 (mean 3.4, SD 0.49). As
stated earlier, the apps are rated according to 4 objective
measures: engagement, functionality, aesthetics, and
information. The functionality dimension mean score achieved
the highest score (3.7), whereas the mean score for the
information and engagement dimensions was the lowest (3.2).
The total mean subjective MARS score (2.8/5) was lower than
the total mean objective MARS score (3.4/5).
On average, the apps had 8 functions based on the IMS criteria
(range 5-11). Two apps achieved the highest IMS functionality
criteria score (11 functions), whereas 2 apps achieved the lowest
score (5 functions). All functions (n=11) are listed in Table 2.
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All apps had collecting, sharing, and recording functionality.
However, half of the apps did not provide clear instructions on
how to enter medication data, did not display vital parameter
data in an easy-to-understand format, and did not guide or
provide users with advice on how or when to take their
medication. Only 2 apps allowed users to communicate with
HCPs, family, and friends in real time.





























a✓: Function present in the app.
Quality Assessment Using the MARS
Four out of the six apps achieved acceptable quality, suggesting
that most apps are of acceptable quality. None of the apps
presented any major technical issues during the review, and all
were updated in the last 2 years. Features included in most apps
reviewed were medication reminders, medication history logs
with the ability to share a medication report with others, vital
parameter tracking, and syncing the account to other devices.
Only one app (Medisafe) achieved the highest objective and
subjective overall MARS scores. One of the distinctive features
of this app was the ability to educate users on how and when
to take their medication, drug-drug interaction information, and
medication side effects. This information was presented in
videos using a clear and concise language and text format. In
addition, there is evidence of effectiveness, as the Medisafe app
has been previously tested in 2 randomized controlled trials
[34,35], as a medication adherence tool using scheduled
reminders [36] and as a medication reminder related to patients’
intention to use the app [37].
The overall subjective quality dimension was significantly lower
(2.8/5) than the overall objective mean of all apps (3.4/5). Only
one app (Medication List & Medical Records) achieved a lower
objective overall score (2.5/5) than the subjective overall score.
The subjective quality represented the opinion of the user on
the level of satisfaction with the app, willingness to pay for it,
and the extent to which the user will recommend it to others. It
appears that the apps reviewed, to a certain extent, are well
designed, as most apps achieved an acceptable objective quality.
However, the subjective quality was poor, as the reviewers
provided lower scores on continuity of use and willingness to
recommend the apps to others.
The functionality dimension mean score achieved the highest
score (3.7), indicating a trend toward higher responses in a
timely manner, intuitiveness and ease of use, and navigation
across all apps. However, the mean score for the information
and engagement dimensions was the lowest (3.2). The
information dimension represents the quality and quantity of
information present in the app and the way this information is
provided, for example, through the use of different formats,
such as videos, text, or graphs. The quality of the information
on the apps reviewed varied, as some provided good quality
medication information; in others, there was a very poor level
of information or none present at all.
None of the apps included in the review performed very well
in the engagement dimension (if the app was fun or interesting
to the user). Medication apps as a rule are not fun and
entertaining; however, most apps allow interactivity (ability to
input information and prompting) and customization (sending
notifications and setting up medication reminders). Another
category in engagement, the target group, evaluated if the app
content (ie, visual information, language, and design) was
appropriate for the user. Most patients diagnosed with HF are
older adults. The apps reviewed were not specifically designed
for use by older adults and did not have an age-friendly
interface. An example of an age-friendly interface is when an
app facilitates older adults to enlarge the font size of the screen
if required. Avoiding information overload and providing
detailed instructions on how to use the app are also age-friendly
interface examples [38]. Three of the apps reviewed (Dosecast,
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Medication List & Medical Records, and MedList Pro) did not
provide clear instructions on how to use the app or how to input
medication. App developers should consult with and take older
adults’views, needs, and preferences into consideration to make
apps more age-friendly and increase usability [38].
IMS Institute for Healthcare Informatics Functionality
Score Evaluation and Implications for Patients With
HF
Inform
Only 2 apps (Medisafe and MyTherapy) communicated
effectively to users, offering an educational component about
medication and the medical condition associated with each
medication. In addition, both apps informed users about the
medication they are taking and possible drug-to-drug
interactions. Due to frequent medication or dosing changes in
patients with HF, this is a critical function. Medication
adherence and continuous education on the condition and
symptom management are vital to reduce rehospitalization,
illness progression, and exacerbation of symptoms in patients
with HF [39].
Instruct
Some of the apps reviewed (Dosecast, Medication List &
Medical Records, and MedList Pro) were not intuitive and did
not provide clear instructions on how to enter medication
strength, time of the day, route, and setting up medication
reminders. In other studies, the level of detailed instructions
varied. Providing clear instructions on the use of an app is vital
for older adults with HF. Patients with HF are predominantly
patients aged ≥ 65 years [40], and old age has been cited as a
barrier to app use and uptake [41]. Therefore, app designers
should consider the needs of older adults using apps and include
basic usability advice and easy-to-understand content [38,42].
Record
All apps allowed users to record their medication and a history
of use. Most apps also had the capability to record vital
parameters. For patients with HF, blood pressure and weight
measurements are useful for monitoring the progress of their
illness and identifying when symptoms exacerbate. One of the
main goals of HF care is to avoid rehospitalization and major
adverse cardiac events [32]. In particular, one app offered the
possibility of tracking mental well-being, another key area that
needs particular attention. For individuals diagnosed with HF,
depression and anxiety are common, leading to rehospitalization,
poorer quality of life, and increased morbidity and mortality
[43].
Evaluate Data
Four apps (MyTherapy, Medication List & Medical Records,
Medisafe, and Pill Reminder) allowed data entered into the app
to be analyzed and evaluated by the user, a relative, or an HCP.
This functionality allows for information to be shared easily
and in a timely manner for HCPs to evaluate it and act
accordingly. For example, relatives and clinicians can evaluate
whether a person is adhering to medication.
Intervene
Five out of the six apps (except Medication List & Medical
Records) had the capability to recommend the user, a relative,
or a medical practitioner to intervene based on the data collected.
Building from the example provided in “evaluate data,” once
the health information is evaluated, an intervention can be put
in place. Examples of interventions for patients with HF could
be to reduce or increase the medication dose, reduce fluid intake,
and attend the clinic or emergency department on the day. Other
examples are the ability of the app to communicate effectively
to provide a positive intervention, that is, reminders to refill
their medication or a suggestion to engage in physical activity
to achieve their daily activity goal.
Display
Apps with a cluttered or bland display do not engage users and
are less likely to offer a positive user experience. In 3 of the
apps reviewed (MyTherapy, Medication List & Medical
Records, and Medisafe), the data were displayed in a clear and
colorful graphical representation format. This function could
potentially be effective for patients with HF as they can easily
understand health reports, that is, medication, weight, and blood
pressure [22]. Consequently, health reports will highlight
behavioral changes, for example, to adhere to the medication
prescribed, reduce fluid intake, or ring the clinic regarding
weight gain.
Guide
Half of the apps (Dosecast, Medication List & Medical Records,
and Pill Reminder) did not provide comprehensive guidance or
training about the correct administration of medication or advice
on the time of day that the medication should be administered,
for example, before or after a meal. HF medication management
is complex, and continuous education and advice on regular
medication use is vital for HF self-management [32].
Reminder or Alert
All apps issued an alert to remind users to take their medication
and most allowed the users to tick off their medication once
they take it or record it as a missed dose. Most apps also had
the capability of reminding users of upcoming medical
appointments. Apps with a reminder function improved
medication adherence and enhanced complex medication
management in patients with HF [32]. One of the apps,
Medisafe, alerted users and their relatives of drug-drug
interactions and of missed medication doses.
Communicate
This function offers the option to communicate with HCPs or
with an online support group in real time. The Medisafe app
offers users the possibility to communicate with unlimited
Medfriends supporters (relatives, friends, or caregivers). Another
app, MyTherapy, provides HCPs with an overview of patients’
data to plan for their treatment between visits through the web
dashboard function.
Google Scholar Search
A search was conducted to identify the apps included in this
review that have been evaluated and published in peer-reviewed
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journals. Out of all the apps reviewed, 3 apps were identified




To our knowledge, this is the first study to assess the quality of
apps with a medication list functionality using the MARS and
the IMS Institute for Healthcare Informatics functionality scale
available to Irish consumers. The most common functionalities
found in the apps reviewed were medication reminders,
medication history logs, and the ability to share medication
reports with others, vital parameter tracking, and syncing the
account to other devices. However, half did not provide clear
instructions on how to enter medication data, did not display
vital parameter data in an easy-to-understand format, and did
not guide users on how or when to take their medication.
App users prefer apps that are effective, useful, and easy to use
[44]. From the apps reviewed, the Medisafe app achieved the
highest objective and subjective overall MARS score and the
highest IMS Institute for Healthcare Informatics functionality
score. One of the distinctive features of this app is the ability
to educate users on how and when to take their medication,
drug-drug interaction information, and medication side effects.
This information was presented in videos using a clear and
concise language and text format. The app was found to be very
intuitive and had an age-friendly interface.
The quality and efficacy of health apps is another important
factor to be considered by users, as they provide positive user
experiences and a higher uptake [45]. Most of the apps included
in this review had acceptable quality. However, for users, it is
not easy to determine the quality, performance, and
trustworthiness of apps. The number of apps available in app
stores has been growing exponentially in the last decade [30,46]
impacting the user’s ability to distinguish app quality and
performance. Therefore, a reliable and easy-to-use tool to
facilitate this process is warranted [47].
The use of mHealth apps is growing at an exponential rate, but
there are questions about their efficacy. One of the methods to
check the evidence of efficacy is to conduct a search for
peer-reviewed academic evidence. For the purpose of this study,
a search was conducted for each app in Google Scholar to
identify any published peer-reviewed articles. Three of the
reviewed apps were identified in the search. The Medisafe app
has been previously tested in 2 randomized controlled trials:
(1) a medication adherence study [34] and (2) a medication
adherence and blood pressure control study [35]. The
MyTherapy app was tested in a study [48] as a medication
tracker and reminder, whereas the Dosecast app was included
in the IMS Institute for Healthcare Informatics review [30], a
MARS review [49], and on a feasibility and acceptability
medication adherence experimental trial [50]. However, many
widely used apps have not yet been scientifically tested.
Therefore, there is a need for more apps to be tested
scientifically and the outcomes to be disseminated to inform
the mHealth research community [22,51].
The mHealth research community has been actively searching
for self-management solutions to support older adults shielding
at home during the COVID-19 pandemic. One of their focus
areas is to support self-management and medication adherence
[52]. Apps with a medication reminder functionality may play
a potentially important role in promoting greater
self-management of vulnerable older adults living at home. In
Ireland, as per March 2021, older adults are shielded, and
movement is restricted to a 5 km radius. The monotonous routine
makes each day very similar to the previous one, and daily
routines, such as taking medication at scheduled times might
become easy to forget. All apps reviewed, with the exception
of one, have the capability of reminding users to take their
medication. Medication reminder apps have been found to be
effective and to increase medication adherence [48,49,53-55],
even for patients with HF [56]. Another app feature that might
be of benefit during the COVID-19 pandemic is the ability of
older adults with HF to communicate with their medical team
or relatives via the app. As mentioned earlier, in Ireland, the
number of in-person HF outpatient consultations has
considerably decreased by 2020 [15,16]. As of March 2021, the
probability of contracting the virus for health care personnel
remains high [57], and patients with HF are considered to be
one of the most vulnerable groups [58].
Finally, this paper identified a small number of apps that could
be suitable for patients with HF sharing their medication list
with HCPs before consultation. Owing to the sensitive nature
of health care data and in an era where General Data Protection
Regulation (GDPR) legislation considerations are increasingly
important, a strict data policy was a criterion for selection. For
example, one of the most frequent concerns app users have is
how their health data are processed. Under GDPR legislation,
app users are encouraged to ask and obtain information in
relation to data security and data processing [59]. However,
after the introduction of the GDPR in 2018, no specific guidance
on privacy has been developed for apps widely available to
consumers [60]. Therefore, the need for transparent and
easy-to-understand strict privacy policies in health apps should
be mandatory if consumers are expected to download and use
mHealth apps [60,61] and if clinicians are expected to
recommend apps to their patients [62].
Conclusions
The quality of current apps with a medication list functionality
varies according to their technical aspects. Most of the reviewed
apps have acceptable MARS objective quality. However, the
subjective quality or satisfaction with the apps was poor. The
objective quality assesses whether an app is interesting, easy to
navigate, and overall visual appeal, among other characteristics.
Subjective quality reflects user satisfaction, app endorsement,
and continuity of use. Only 3 apps are based on scientific
evidence and have been tested previously. Two apps featured
all the IMS Institute for Healthcare Informatics functionalities
and half did not provide clear instructions on how to enter
medication data, did not display vital parameter data in an
easy-to-understand format, and did not guide users on how or
when to take their medication.
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To our knowledge, this is the first study to use the MARS to
assess the quality of apps with a medication list functionality
available in the Irish app stores. The need for an app to support
older adults with HF to maintain an accurate medication list is
warranted. We recommend that app developers display either
in the app or on the website, a transparent and
easy-to-understand privacy policy to increase patients’ and
HCPs’ trust and use.
Limitations
One of the limitations of this review is the limited number of
apps, as only those with a strict privacy policy written on their
website or app store were included. Furthermore, due to the fast
pace of app development, it is possible that by the time this
paper is published, there may be new apps with a medication
list functionality available to Irish consumers.
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